<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35410933</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol.</ArticleTitle><Pagination><StartPage>e057885</StartPage><MedlinePgn>e057885</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e057885</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2021-057885</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as 'post COVID-19 syndrome', 'post-COVID condition' or more commonly 'Long COVID'. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments.</AbstractText><AbstractText Label="AIMS">This review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">Primary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">This systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER">The review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074).</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chandan</LastName><ForeName>Joht Singh</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-9561-5141</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK j.s.chandan.1@bham.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Kirsty</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9403-1593</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simms-Williams</LastName><ForeName>Nikita</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4926-1995</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camaradou</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>COVID END Evidence Network, UK, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Nasir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Dentistry, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heining</LastName><ForeName>Dominic</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiyegbusi</LastName><ForeName>Olalekan Lee</ForeName><Initials>OL</Initials><Identifier Source="ORCID">0000-0001-9122-8251</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research (NIHR) Applied Research Centre West Midlands, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Grace</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9783-9413</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz Rivera</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1566-6804</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hotham</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nirantharakumar</LastName><ForeName>Krishnarajah</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khunti</LastName><ForeName>Kamlesh</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2343-7099</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raindi</LastName><ForeName>Devan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Dentistry, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marwaha</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Mental Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0001-5656-1198</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research (NIHR) Applied Research Centre West Midlands, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMullan</LastName><ForeName>Christel</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0878-1513</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvert</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1856-837X</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research (NIHR) Applied Research Centre West Midlands, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Patient Reported Outcomes Research and Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haroon</LastName><ForeName>Shamil</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0096-1413</Identifier><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_20050</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">INFECTIOUS DISEASES</Keyword><Keyword MajorTopicYN="N">REHABILITATION MEDICINE</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35410933</ArticleId><ArticleId IdType="pmc">PMC9002258</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2021-057885</ArticleId><ArticleId IdType="pii">bmjopen-2021-057885</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>John Hopkins University . COVID-19 Map - Johns Hopkins Coronavirus Resource Center, 2020. Available: https://coronavirus.jhu.edu/map.html [Accessed 8 Jun 2020].</Citation></Reference><Reference><Citation>Haas EJ, Angulo FJ, McLaughlin JM, et al. . Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021;397:1819&#x2013;29. 10.1016/S0140-6736(21)00947-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00947-8</ArticleId><ArticleId IdType="pmc">PMC8099315</ArticleId><ArticleId IdType="pubmed">33964222</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health England . Direct and indirect impact of the vaccination programme on COVID-19 infections and mortality, 2021.</Citation></Reference><Reference><Citation>Gupta S, Cantor J, Simon KI, et al. . Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States. Health Aff 2021;40:1465&#x2013;72. 10.1377/hlthaff.2021.00619</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2021.00619</ArticleId><ArticleId IdType="pmc">PMC9937640</ArticleId><ArticleId IdType="pubmed">34406840</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C, et al. . Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir Med 2020;174:106197. 10.1016/j.rmed.2020.106197</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106197</ArticleId><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms 1 collected by the Covid symptoms study APP 2 3 medRxiv preprint. medRxiv 2020.</Citation></Reference><Reference><Citation>et alWhitaker M, Elliott J, Chadeau-Hyam M. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people, 2021. Available: http://spiral.imperial.ac.uk/handle/10044/1/89844 [Accessed 10 Sep 2021].</Citation></Reference><Reference><Citation>Office for National Statistics . Short report on long COVID, 2021. Available: https://www.gov.uk/government/publications/ons-short-report-on-long-covid-22-july-2021 [Accessed 10 Sep 2021].</Citation></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021;6:100122. 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et al. . Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021;372:n693. 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA. Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from Hospital: a cohort study. Lancet 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, et al. . Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med 2021;8:653516. 10.3389/fmed.2021.653516</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health and Care Excellence . Identifying people with ongoing symptomatic COVID-19 or post-COVID-19 syndrome | COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2020.. Available: https://www.nice.org.uk/guidance/ng188/chapter/1-Identifying-people-with-ongoing-symptomatic-COVID-19-or-post-COVID-19-syndrome [Accessed 10 Sep 2021].</Citation></Reference><Reference><Citation>Aucott JN, Rebman AW. Long-haul COVID: heed the lessons from other infection-triggered illnesses. Lancet 2021;397:967&#x2013;8. 10.1016/S0140-6736(21)00446-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00446-3</ArticleId><ArticleId IdType="pmc">PMC7952095</ArticleId><ArticleId IdType="pubmed">33684352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, et al. . Long COVID guidelines need to reflect lived experience. Lancet 2021;397:455&#x2013;7. 10.1016/S0140-6736(20)32705-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton A, Olliaro P, Sigfrid L, et al. . Long COVID: tackling a multifaceted condition requires a multidisciplinary approach. Lancet Infect Dis 2021;21:601&#x2013;2. 10.1016/S1473-3099(21)00043-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00043-8</ArticleId><ArticleId IdType="pmc">PMC7906694</ArticleId><ArticleId IdType="pubmed">33548193</ArticleId></ArticleIdList></Reference><Reference><Citation>International Committee on taxonomy of viruses. taxonomy, 2020. Available: https://talk.ictvonline.org/taxonomy/ [Accessed 4 Jul 2021].</Citation></Reference><Reference><Citation>Hui DS, Wong KT, Ko FW, et al. . The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005;128:2247&#x2013;61. 10.1378/chest.128.4.2247</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.4.2247</ArticleId><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong K-C, Ng AW-K, Lee LS-U, et al. . 1-Year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest 2005;128:1393&#x2013;400. 10.1378/chest.128.3.1393</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.3.1393</ArticleId><ArticleId IdType="pmc">PMC7094739</ArticleId><ArticleId IdType="pubmed">16162734</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh M-J, Lee W-C, Cho H-Y, et al. . Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis. Influenza Other Respir Viruses 2018;12:643&#x2013;8. 10.1111/irv.12566</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12566</ArticleId><ArticleId IdType="pmc">PMC6086854</ArticleId><ArticleId IdType="pubmed">29676537</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W-H, Guo Y-S, Zhang D-H, et al. . Long-Term prognosis of suspected myocarditis and cardiomyopathy associated with viral infection of the myocardial tissue: a meta-analysis of cohort studies. Cardiovasc Ther 2019;2019:1&#x2013;10. 10.1155/2019/9342792</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9342792</ArticleId><ArticleId IdType="pmc">PMC6942786</ArticleId><ArticleId IdType="pubmed">31921354</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz JC, Hilliard AA, Cooper LT, et al. . Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 2009;84:1001&#x2013;9. 10.1016/S0025-6196(11)60670-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-6196(11)60670-8</ArticleId><ArticleId IdType="pmc">PMC2770911</ArticleId><ArticleId IdType="pubmed">19880690</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KS, Zheng JP, Mok YW, et al. . Sars: prognosis, outcome and sequelae. Respirology 2003;8 Suppl:S36&#x2013;40. 10.1046/j.1440-1843.2003.00522.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1843.2003.00522.x</ArticleId><ArticleId IdType="pmc">PMC7169213</ArticleId><ArticleId IdType="pubmed">15018132</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et al. . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020;7:611&#x2013;27. 10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Shin H-S, Park HY, et al. . Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle East respiratory syndrome survivors. Psychiatry Investig 2019;16:59&#x2013;64. 10.30773/pi.2018.10.22.3</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006;333:575&#x2013;8. 10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD. What causes prolonged fatigue after infectious mononucleosis: and does it tell us anything about chronic fatigue syndrome? J Infect Dis 2007;196:4&#x2013;5. 10.1086/518615</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/518615</ArticleId><ArticleId IdType="pubmed">17538875</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, et al. . Symptoms, complications and management of long COVID: a review. J R Soc Med 2021;114:428&#x2013;42. 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik S, Asprusten TT, Pedersen M, et al. . Cognitive&#x2013;behavioural therapy combined with music therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: a randomised controlled trial. BMJ Paediatr Open 2020;4:e000797. 10.1136/bmjpo-2020-000797</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjpo-2020-000797</ArticleId><ArticleId IdType="pmc">PMC7580073</ArticleId><ArticleId IdType="pubmed">33117895</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal AS, Bradley AS, Bishop KN, et al. . Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun 2012;26:24&#x2013;31. 10.1016/j.bbi.2011.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.06.016</ArticleId><ArticleId IdType="pubmed">21756995</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A, Marshall T. Myalgic Encephalomyelitis/Chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front Pediatr 2018;6:373. 10.3389/fped.2018.00373</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00373</ArticleId><ArticleId IdType="pmc">PMC6288442</ArticleId><ArticleId IdType="pubmed">30564562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamato M, Kataoka Y. Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions? Neural Regen Res 2015;10:203&#x2013;4. 10.4103/1673-5374.152369</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.152369</ArticleId><ArticleId IdType="pmc">PMC4392663</ArticleId><ArticleId IdType="pubmed">25883614</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-Viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomedicine, Health Behav 2020;8:61&#x2013;9. 10.1080/21641846.2020.1778227</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2020.1778227</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Whistler T, Cameron B, et al. . Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis 2006;6:15. 10.1186/1471-2334-6-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-6-15</ArticleId><ArticleId IdType="pmc">PMC1373655</ArticleId><ArticleId IdType="pubmed">16448567</ArticleId></ArticleIdList></Reference><Reference><Citation>Holgate ST, Komaroff AL, Mangan D, et al. . Chronic fatigue syndrome: understanding a complex illness. Nat Rev Neurosci 2011;12:539&#x2013;44. 10.1038/nrn3087</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3087</ArticleId><ArticleId IdType="pubmed">21792218</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, et al. . Long covid-mechanisms, risk factors, and management. BMJ 2021;374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>UKRI . Outcomes of the UK COVID-19 therapeutics Advisory panel (UK-CTAP), 2021. Available: https://www.ukri.org/about-us/policies-standards-and-data/data-collection/uk-covid-19-therapeutics-advisory-panel/ [Accessed 27 Sep 2021].</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647. 10.1136/bmj.g7647</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett JE, Dolin R, Blaser MJ. Principles and practice of infectious diseases, 2019.</Citation></Reference><Reference><Citation>World Health Organization . A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021, 2021. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [Accessed 2 Mar 2022].</Citation></Reference><Reference><Citation>Veritas health innovation. Covidence systematic review software.</Citation></Reference><Reference><Citation>Shea BJ, Reeves BC, Wells G, et al. . AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008. 10.1136/bmj.j4008</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j4008</ArticleId><ArticleId IdType="pmc">PMC5833365</ArticleId><ArticleId IdType="pubmed">28935701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. secondary the Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hosp Res Inst 2015:2&#x2013;4.</Citation></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. . Rob 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. 10.1136/bmj.l4898</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919. 10.1136/bmj.i4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane . 16.1.2 general principles for dealing with missing data. Available: https://handbook-5-1.cochrane.org/chapter_16/16_1_2_general_principles_for_dealing_with_missing_data.htm [Accessed 10 Sep 2021].</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. . Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924&#x2013;6. 10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Staniszewska S, Brett J, Simera I. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ 2017;358:3453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5539518</ArticleId><ArticleId IdType="pubmed">28768629</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>